138 related articles for article (PubMed ID: 30682521)
1. Interleukin-6 and amyotrophic lateral sclerosis.
Pronto-Laborinho A; Pinto S; Gromicho M; Pereira M; Swash M; de Carvalho M
J Neurol Sci; 2019 Mar; 398():50-53. PubMed ID: 30682521
[TBL] [Abstract][Full Text] [Related]
2. Plasma level of club-cell (CC-16) predicts outcome in amyotrophic lateral sclerosis.
Pronto-Laborinho AC; Gromicho M; Pereira M; Pinto S; Barros MDA; Swash M; de Carvalho M
Acta Neurol Scand; 2018 Feb; 137(2):233-237. PubMed ID: 28967121
[TBL] [Abstract][Full Text] [Related]
3. Humoral factors in ALS patients during disease progression.
Ehrhart J; Smith AJ; Kuzmin-Nichols N; Zesiewicz TA; Jahan I; Shytle RD; Kim SH; Sanberg CD; Vu TH; Gooch CL; Sanberg PR; Garbuzova-Davis S
J Neuroinflammation; 2015 Jun; 12():127. PubMed ID: 26126965
[TBL] [Abstract][Full Text] [Related]
4. The terminal latency of the phrenic nerve correlates with respiratory symptoms in amyotrophic lateral sclerosis.
Park JS; Park D
Clin Neurophysiol; 2017 Sep; 128(9):1625-1628. PubMed ID: 28719826
[TBL] [Abstract][Full Text] [Related]
5. Assessment of respiratory functions by spirometry and phrenic nerve studies in patients of amyotrophic lateral sclerosis.
Singh D; Verma R; Garg RK; Singh MK; Shukla R; Verma SK
J Neurol Sci; 2011 Jul; 306(1-2):76-81. PubMed ID: 21496826
[TBL] [Abstract][Full Text] [Related]
6. Correlation between Forced Vital Capacity and Slow Vital Capacity for the assessment of respiratory involvement in Amyotrophic Lateral Sclerosis: a prospective study.
Pinto S; de Carvalho M
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):86-91. PubMed ID: 27915482
[TBL] [Abstract][Full Text] [Related]
7. Lower serum lipid levels are related to respiratory impairment in patients with ALS.
Chiò A; Calvo A; Ilardi A; Cavallo E; Moglia C; Mutani R; Palmo A; Galletti R; Marinou K; Papetti L; Mora G
Neurology; 2009 Nov; 73(20):1681-5. PubMed ID: 19917991
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound for assessment of diaphragm in ALS.
Pinto S; Alves P; Pimentel B; Swash M; de Carvalho M
Clin Neurophysiol; 2016 Jan; 127(1):892-897. PubMed ID: 25971723
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal assessment of clinical and inflammatory markers in patients with amyotrophic lateral sclerosis.
Prado LGR; Rocha NP; de Souza LC; Bicalho ICS; Gomez RS; Vidigal-Lopes M; Braz NFT; Vieira ÉLM; Teixeira AL
J Neurol Sci; 2018 Nov; 394():69-74. PubMed ID: 30219498
[TBL] [Abstract][Full Text] [Related]
10. Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis.
Ono S; Hu J; Shimizu N; Imai T; Nakagawa H
J Neurol Sci; 2001 Jun; 187(1-2):27-34. PubMed ID: 11440741
[TBL] [Abstract][Full Text] [Related]
11. Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R.
Jackson C; De Carvalho M; Genge A; Heiman-Patterson T; Shefner JM; Wei J; Wolff AA
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):506-512. PubMed ID: 30379086
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of phrenic latency and forced vital capacity in patients with ALS with latent respiratory dysfunction.
Kwon S; Min JH; Cho HJ; Joo BE; Cho EB; Seok JM; Kim MJ; Kim BJ
Clin Neurophysiol; 2015 Jul; 126(7):1421-6. PubMed ID: 25454281
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary function tests and diaphragmatic compound muscle action potential in patients with sporadic amyotrophic lateral sclerosis.
Sathyaprabha TN; Pradhan C; Nalini A; Thennarasu K; Raju TR
Acta Neurol Scand; 2010 Jun; 121(6):400-5. PubMed ID: 20070278
[TBL] [Abstract][Full Text] [Related]
14. Phrenic nerve conduction studies as a biomarker of respiratory insufficiency in amyotrophic lateral sclerosis.
Jenkins JA; Sakamuri S; Katz JS; Forshew DA; Guion L; Moore D; Miller RG
Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(3-4):213-20. PubMed ID: 26618854
[TBL] [Abstract][Full Text] [Related]
15. Changes of the phrenic nerve motor response in amyotrophic lateral sclerosis: longitudinal study.
Pinto S; Geraldes R; Vaz N; Pinto A; de Carvalho M
Clin Neurophysiol; 2009 Dec; 120(12):2082-2085. PubMed ID: 19833553
[TBL] [Abstract][Full Text] [Related]
16. Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study.
Hu Y; Cao C; Qin XY; Yu Y; Yuan J; Zhao Y; Cheng Y
Sci Rep; 2017 Aug; 7(1):9094. PubMed ID: 28831083
[TBL] [Abstract][Full Text] [Related]
17. Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis.
Andrews JA; Meng L; Kulke SF; Rudnicki SA; Wolff AA; Bozik ME; Malik FI; Shefner JM
JAMA Neurol; 2018 Jan; 75(1):58-64. PubMed ID: 29181534
[TBL] [Abstract][Full Text] [Related]
18. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
[TBL] [Abstract][Full Text] [Related]
19. Phrenic nerve studies predict survival in amyotrophic lateral sclerosis.
Pinto S; Pinto A; de Carvalho M
Clin Neurophysiol; 2012 Dec; 123(12):2454-9. PubMed ID: 22762911
[TBL] [Abstract][Full Text] [Related]
20. Comparison of slow and forced vital capacities on ability to predict survival in ALS.
Pinto S; de Carvalho M
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):528-533. PubMed ID: 28741375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
